肿瘤·癌症标记的全球市场

Tumor / Cancer Markers

出版日期: 2023年01月01日 | 出版商:

Global Industry Analysts, Inc. | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球肿瘤·癌症标记的市场规模由于COVID-19后商务形势的变化，在2022年估算为2022年39亿美元，在2030年前达到65亿美元，在分析期间 (2022年～2030年) 年复合成长率预计将为6.7％。

本报告提供全球肿瘤·癌症标记市场的相关调查，提供Covid-19影响，趋势和成长要素，各地区的市场分析，竞争情形，主要企业的简介等资讯。

分析对像企业一例 (全84公司)

20/20 Genesystems, Inc.
Abbott Diagnostics
AC Immune SA
Acuamark Diagnostics
Advanced Cell Diagnostics, Inc.
Affimedix, Inc.
Agilent Technologies, Inc.
Alere, Inc.
Alexion Pharmaceuticals, Inc.
ARUP Laboratories

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Tumor / Cancer Markers Market to Reach $6.5 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Tumor / Cancer Markers estimated at US$3.9 Billion in the year 2022, is projected to reach a revised size of US$6.5 Billion by 2030, growing at a CAGR of 6.7% over the period 2022-2030.

The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 10.8% CAGR

The Tumor / Cancer Markers market in the U.S. is estimated at US$1.1 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 10.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 6.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Select Competitors (Total 84 Featured):

20/20 Genesystems, Inc.
Abbott Diagnostics
AC Immune SA
Acuamark Diagnostics
Advanced Cell Diagnostics, Inc.
Affimedix, Inc.
Agilent Technologies, Inc.
Alere, Inc.
Alexion Pharmaceuticals, Inc.
ARUP Laboratories

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Tumor / Cancer Markers - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- TABLE 2: World Historic Review for Tumor / Cancer Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- TABLE 3: World 16-Year Perspective for Tumor / Cancer Markers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
- TABLE 4: World Tumor / Cancer Markers Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
- Tumor / Cancer Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- TABLE 5: USA Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 6: USA Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
CANADA
- TABLE 7: Canada Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 8: Canada Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
JAPAN
- Tumor / Cancer Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- TABLE 9: Japan Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 10: Japan Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
CHINA
- Tumor / Cancer Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- TABLE 11: China Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 12: China Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
EUROPE
- Tumor / Cancer Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- TABLE 13: Europe Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- TABLE 14: Europe Historic Review for Tumor / Cancer Markers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- TABLE 15: Europe 16-Year Perspective for Tumor / Cancer Markers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
FRANCE
- Tumor / Cancer Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- TABLE 16: France Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 17: France Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
GERMANY
- Tumor / Cancer Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- TABLE 18: Germany Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 19: Germany Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
ITALY
- TABLE 20: Italy Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 21: Italy Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
UNITED KINGDOM
- Tumor / Cancer Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- TABLE 22: UK Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 23: UK Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
SPAIN
- TABLE 24: Spain Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 25: Spain Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
RUSSIA
- TABLE 26: Russia Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 27: Russia Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
REST OF EUROPE
- TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 29: Rest of Europe Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
ASIA-PACIFIC
- Tumor / Cancer Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- TABLE 31: Asia-Pacific Historic Review for Tumor / Cancer Markers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- TABLE 32: Asia-Pacific 16-Year Perspective for Tumor / Cancer Markers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
AUSTRALIA
- Tumor / Cancer Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
- TABLE 33: Australia Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 34: Australia Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
INDIA
- Tumor / Cancer Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
- TABLE 35: India Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 36: India Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
SOUTH KOREA
- TABLE 37: South Korea Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 38: South Korea Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
REST OF ASIA-PACIFIC
- TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 40: Rest of Asia-Pacific Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
LATIN AMERICA
- Tumor / Cancer Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
- TABLE 41: Latin America Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- TABLE 42: Latin America Historic Review for Tumor / Cancer Markers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- TABLE 43: Latin America 16-Year Perspective for Tumor / Cancer Markers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
ARGENTINA
- TABLE 44: Argentina Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 45: Argentina Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
BRAZIL
- TABLE 46: Brazil Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 47: Brazil Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
MEXICO
- TABLE 48: Mexico Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 49: Mexico Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
REST OF LATIN AMERICA
- TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 51: Rest of Latin America Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
MIDDLE EAST
- Tumor / Cancer Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
- TABLE 52: Middle East Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- TABLE 53: Middle East Historic Review for Tumor / Cancer Markers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- TABLE 54: Middle East 16-Year Perspective for Tumor / Cancer Markers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
IRAN
- TABLE 55: Iran Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 56: Iran Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
ISRAEL
- TABLE 57: Israel Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 58: Israel Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
SAUDI ARABIA
- TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 60: Saudi Arabia Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
UNITED ARAB EMIRATES
- TABLE 61: UAE Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 62: UAE Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
REST OF MIDDLE EAST
- TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 64: Rest of Middle East Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
AFRICA
- Tumor / Cancer Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
- TABLE 65: Africa Recent Past, Current & Future Analysis for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- TABLE 66: Africa Historic Review for Tumor / Cancer Markers by Segment - Tumor / Cancer Markers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR